Prelude Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Prelude Capital Management's HALO Position: Q1 2026 in Review
Prelude Capital Management sold out of Halozyme (HALO) in Q1 2026, closing a stake of 3,589 shares — an estimated $242K sold.
Prelude Capital Management first reported a position in HALO in Q2 2013 and held it in 18 quarters. The position peaked at $578K in Q1 2018. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Prelude Capital Management reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
- Prelude Capital Management sold 3,589 Halozyme shares in Q1 2026, an estimated $242K.
- Prelude Capital Management first reported a position in Halozyme in Q2 2013 and held it in 18 quarters.
- Prelude Capital Management's Halozyme position peaked at $578K in Q1 2018.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.